Two sharply contrasting insider trade clusters filed this week stand out in the ORTEX data.
GeneDx Holdings attracted aggressive buying from two board-linked funds. Corvex Management and Casdin Capital filed purchases totalling over $35M across multiple days in May. Casdin, a 10% owner with board representation, bought 500,000 shares between May 18–20 alone. Corvex added another roughly 600,000 shares in early May. This coordinated accumulation signals high conviction in the genomic diagnostics firm.
On the selling side, Chevron director John Hess filed sales of over $71M across two separate rounds — May 6 and May 20. The trades covered nearly 570,000 shares. While director sales are not always alarming, the size and repetition here is notable.
Perimeter Solutions CEO Haitham Khouri filed sales of roughly $6.6M over three consecutive days (May 20–22), offloading more than 229,000 shares at prices between $31 and $34. That cluster, filed on May 22, represents one of the more prominent CEO disposals of the past fortnight.
Arm Holdings also saw three insiders file combined sales of in the same period, adding to broader pressure on the chip-designer's insider sentiment.
This article is not financial advice.
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
